Cordis and BrosMed launch ceremony for the localization strategy at CIIE China
2023-11-09

Cordis and BrosMed launch ceremony for the localization strategy at CIIE China

Cordis and BrosMed launched ceremony for the localization strategy in China and will continue to uphold the mutual original commitment to innovation, maintain a patient-centered philosophy, persistently cultivate in the field of vascular intervention, and convey care to vascular disease patients worldwide.

ESVS 2023 丨Prof. Qizhuang Jin’s team: 12-month results of a peripheral intervention  scoring balloon dilatation catheter (BrosMed Tri-Wedge™) in the treatment of stenotic lesions of arteriovenous fistula
2023-10-19

ESVS 2023 丨Prof. Qizhuang Jin’s team: 12-month results of a peripheral intervention scoring balloon dilatation catheter (BrosMed Tri-Wedge™) in the treatment of stenotic lesions of arteriovenous fistula

The 37th Annual Meeting of the European Society for Vascular […]

BrosMed Medical Earns MDSAP Certification
2023-06-21

BrosMed Medical Earns MDSAP Certification

This certification confirms BrosMed’s compliance with the high standards and regulatory requirements of most leading countries in the world.

BrosMed’s POT™ NC PTCA Balloon Dilatation Catheter Receives FDA 510(k) Clearance
2023-04-12

BrosMed’s POT™ NC PTCA Balloon Dilatation Catheter Receives FDA 510(k) Clearance

BrosMed POT PTCA balloon is the world’s first dedicated balloon for proximal optimization technique (POT) and distal optimization technique (DOT) in bifurcation stenting.

BrosMed Announced CE MDR Approval of Tiche™ 0.035”High Pressure PTA Balloon Dilatation Catheter
2023-03-21

BrosMed Announced CE MDR Approval of Tiche™ 0.035”High Pressure PTA Balloon Dilatation Catheter

Tiche™ 0.035” High Pressure PTA Balloon Dilatation Catheter is designed for the treatment of severely calcified peripheral vascular disease and challenging AV cases.